Results - Announcements
Hester Biosciences Ltd share price gained 4.34% to Rs 2419.55 after the company's net profit witnessed a sharp fall of 78.67% to Rs 20.63 crore, while revenue from operations increased sharply by 26.76% to Rs 97.91 crore in Q3FY26 over Q2FY26.
The market capitalization of Pharmaceuticals industry group stocks on BSE stood at Rs 27.82 lakh crore, rising 5.09%. It has marginally improved by 2.18% over last one week and gained upto 2.72% in last one month while the market capitalization of Hester Biosciences Ltd has improved by 5.21% and 0.02% in the same period respectively.
Profit before tax (PBT) of Hester Biosciences Ltd stood at Rs 26.45 crore in Q3 FY26, jumping 55.22% year-on-year, and nosediving by 73.99% quarter-on-quarter. EBITDA came in at Rs 31 crore, rallying 1472.22% YoY and expanding by 47.33% sequentially.
Total expenses went up by 17.59% to Rs 72.33 crore in Q3FY26 over Q3FY25. During the quarter, cost of materials consumed stood at Rs 15.75 crore, advancing by 14.80% YoY, while employee benefits expense was at Rs 15.34 crore, easing 3.09% YoY.
For the TTM ended FY26, revenue from operations posted a slight growth of 6.91% to Rs 332.6 crore, while net profit saw a strong growth of 99.38% to Rs 57.48 crore, compared to previous TTM. EBITDA jumped by 5821% to Rs 76.98 crore, and PBT jumped 91.66% to Rs 75.84 crore compared to previous TTM.
The company's consolidated net cash flow from operating activities stood at Rs 64.14 crore in FY26, as against Rs 64.51 crore in FY25.
Hester Biosciences Ltd surged by 51.97% in last one year, significantly outperforming the benchmark BSE Sensex which has softened by 4.80% during the same period.